Boston Scientific picks Barclays for £3.3bn BTG buy

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Syndicated Loans

Boston Scientific picks Barclays for £3.3bn BTG buy

Mike Turner
November 20, 2018 02:15 PM
Barclays 2

Boston Scientific, the US medical devices manufacturer, has agreed to buy the UK’s BTG for £3.3bn, with Barclays providing a bridge loan to finance the medical industry transaction and continue the trend of borrowers turning to small banking groups to fund purchases.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansUKEuropeBarclaysEMEA
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article